[1]
“Benefits of Rosuvastatin in Cardiovascular Protection Remain Unclear After HOPE-3 ”, Rev Diabet Stud, vol. 13, no. 4, Aug. 2016, Accessed: Jan. 19, 2026. [Online]. Available: https://www.diabeticstudies.org/index.php/RDS/article/view/93